Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210

Chen XueLian; Ma Lanying; Xu Binghe

doi:10.20892/j.issn.2095-3941.2018.0172

Clinical Trial

Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210

CI 8.40

Jan 1, 2019

Published

Abstract

RCHs were prevalent but manageable during treatment with SHR-1210. It might add to the expanding literature regarding immune-related dermatologic adverse events.

Research Topics

Paper Details

Title: Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210
DOI: 10.20892/j.issn.2095-3941.2018.0172
Published: Jan 1, 2019
Journal
Volume: 16
Issue: 1
Pages: 173–173